In patients with SLE, besides the higher levels of anti-annexin-V antibodies, serum anti-annexin-V levels were shown to be predictive of poorer endothelial function gauged by endothelium-dependent vasodilation [111–113]. This evidence concerns the gene ANXA5 and systemic lupus erythematosus.